Related Experiment Video
Updated: Jun 6, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Advancements in p53-Based Anti-Tumor Gene Therapy Research
Yuanwan Peng1, Jinping Bai1, Wang Li1
1Institute of Modern Fermentation Engineering and Future Foods, School of Light Industry and Food Engineering, Guangxi University, No. 100, Daxuedong Road, Nanning 530004, China.
Abstract:
The p53 gene is one of the genes most closely associated with human tumors and has become a popular target for tumor drug design. Currently, p53-based gene therapy techniques have been developed, but these therapies face challenges such as immaturity, high safety hazards, limited efficacy, and low patient acceptance. However, researchers are no less enthusiastic about the treatment because of its theoretical potential to treat cancer. In this paper, the advances in p53-based gene therapy and related nucleic acid delivery technologies were reviewed and prospected in order to support further development in this field.
Insights
p53 gene therapy shows promise for cancer treatment but faces challenges. This review explores advances in p53 gene therapy and nucleic acid delivery to overcome these hurdles and support future development.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- The p53 gene is a critical tumor suppressor frequently altered in human cancers.
- p53-based gene therapy is a promising strategy for cancer treatment.
- Current p53 gene therapies face significant challenges including immaturity, safety concerns, limited efficacy, and patient acceptance.
Purpose of the Study:
- To review recent advances in p53-based gene therapy.
- To examine progress in nucleic acid delivery technologies for p53 gene therapy.
- To provide insights and prospects for future development in this field.
Main Methods:
- Literature review of p53 gene therapy.
- Analysis of nucleic acid delivery systems.
- Discussion of challenges and future directions.
Main Results:
- Significant progress has been made in p53 gene therapy development.
- Novel nucleic acid delivery technologies are emerging to improve therapeutic outcomes.
- Despite challenges, the theoretical potential of p53 gene therapy remains high.
Conclusions:
- Further research and technological advancements are crucial for overcoming current limitations.
- Improved nucleic acid delivery systems are key to enhancing p53 gene therapy efficacy and safety.
- p53 gene therapy holds considerable potential for future cancer treatment strategies.
More Related Videos
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...